Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macimorelin in Cancer Cachexia
NCT01614990Phase 2Completed
- Start
- May 2012
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of macimorelin in cancer cachexia. Started May 2012; status: completed.
02
Drugs
macimorelin
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT01614990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614990.